26.04.2018
- Shire has announced that it would be willing to recommend Takeda’s latest and fifth proposal to its shareholders. The revised offer, Takeda’s fifth in recent weeks, values Shire at...
24.04.2018
- Japanese drugmaker Takeda has hiked its bid for Shire, also increasing the cash part of the deal. In its latest proposal, made on Apr. 20, Takeda has offered £47 per share, valuing...
04.04.2018
- Japanese drugmaker Takeda has announced that it is considering buying Ireland-domiciled drugmaker Shire, although it stressed that the offer was “at a preliminary and exploratory...
26.03.2018
- TiGenix and Takeda’s Alofisel has won clearance from the European Commission, making it the first allogeneic stem cell therapy to be approved for use in Europe. Alofisel...
The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500...
01.09.2017
- AstraZeneca and Takeda have agreed to jointly develop and commercialize a potential treatment for Parkinson’s disease. The companies will collaborate to advance MEDI1341, an...
24.03.2017
- UK healthcare and life science company Arix Bioscience has signed an agreement with the Lead Discovery Center (LDC), Max Planck Innovation and the University of Leeds to develop...
17.01.2017
- On behalf of shareholders of Ariad Pharmaceuticals who claim their interests were not fairly represented in the sale of the company to Japanese drugmaker Takeda for $5.2 billion...
